About Us
What We Do
History
Our Management
Science
ASODE™
C-Duplex™
Pipeline
Pipeline
ASO
Fixed-Dose
Combination
News
Announcement
News
Notice
Contact
Contact Us
Address
Careers
KOR
ENG
News
News
News
No.
Title
Date
8
Autotelic Bio Successfully Raised KRW 15.5 Billion in Series B Investment
2022-03-28
7
ATB-101, a Fixed Dose Combination for Hypertension and Diabetes Got IND Approval for Phase 1 Clinical Trial
2021-03-02
6
Autotelic Bio Signed Agreement with Clinigen for Clinical Trials of Anti-cancer New Drug
2021-01-14
5
Autotelic Bio Raised Strategic Investment
2020-09-06
4
Autotelic Bio Raised Series A Investment
2020-01-07
3
Autotelic Bio-ST Pharm Signed Agreement for Manufacturing and Supplying Trabederson
2019-05-28
2
ATB-301 Selected in "Pharm Navi" Project by MFDS
2019-04-18
1
Jeil Pharmaceutical Signed Joint Development and Strategic Investment Agreement for ATB-101 with Autotelic Bio
2019-01-31
1
2
